CHMP clears path for GSK’s Blenrep re­launch, rec­om­mends four oth­er drugs 

GSK, Roche and Spring­Works Ther­a­peu­tics were among those that se­cured a pos­i­tive opin­ion for new drugs from the Eu­ro­pean Med­i­cines Agency’s hu­man med­i­cines com­mit­tee …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER